Bayer buying Merck's consumer product lines

Merck: User-Friendly Global Recognition

Merck earnings beat on top and bottom lines, raises forecast

Merck to buy cancer drug developer ArQule for $2.7B in cash

Merck sues U.S. government over Medicare drug price negotiations

Patients - Merck.com

Merck buys Idenix for $3.85 billion

Merck ends Covid vaccine program but continues work on treatments

Merck CEO: Significant Need for New Blockbuster Drugs